Sequential tofacitinib and low-dose interleukin-2 therapy: reassessing biomarkers and mechanistic gaps in alopecia areata

Shiuan-Chih ChenYuan-Ti Lee2026-03-102026-03-102025-10-1710.1093/qjmed/hcaf249https://scholars.csmu.edu.tw/handle/123456789/5427Sequential tofacitinib and low-dose interleukin-2 therapy: reassessing biomarkers and mechanistic gaps in alopecia areatajournal-article